Work

Impact of meticillin-resistant Staphylococcus aureus rapid molecular testing on hospital-related quality and cost of care

Year: 2025
Type: article
Abstract: BACKGROUND: The implementation of proactive screening has reduced meticillin-resistant Staphylococcus aureus (MRSA) infections in hospital settings. AIM: To evaluate the health and cost implications of a rapid polymerase chain reaction (PCR)-based testing strategy compared to conventional strategies for MRSA control. METHODS: A cost-consequence analysis incorporating conventional interventional and infection-related expenditures was developed to estimate the health and economic impact of rapid PCR-based screening compared to no screening, universal decolonization, and culture-based screening from a US hospital perspective. The analysis included patients hospitalized in general wards at risk of MRSA infection over a 30-day time horizon. The model inputs were informed by the published literature. Sensitivity and scenario analyses were conducted to examine the impact of key parameters and assumptions. FINDINGS: In a 1000-patient cohort, compared to culture-based screening with and without pre-emptive isolation, the rapid PCR-based screening saved US$11,842,498 and $5,625,278, respectively, in total costs and reduced health outcomes while resulting in fewer infections, deaths, and onward transmissions compared to conventional culture screening without pre-emptive isolation. Compared to universal decolonization, the rapid PCR-based strategy saved $12,353,893 in total costs. Although the total costs increased for molecular screening due to higher bed-day costs compared to no active screening, the rapid PCR-based strategy averted infections, subsequent deaths, and onward transmissions. Sensitivity and scenario analyses confirmed the robustness of these findings. CONCLUSION: Compared to other interventional strategies to reduce MRSA-related sequelae in the hospital setting, routine testing with rapid PCR-based screening shows potential for improved health outcomes and cost savings.
Language: English
Field: Medicine
Open Access status: hybrid
Estimated APC paid: $4,000
Funder: Cepheid
OpenAlex ID: W4414997653
FWCI: 2.196
Cites: 25
Cited by: 3
Related to: